Randomized Comparative Trial for Persistent Pain in Spinal Cord Injury: Acupuncture vs Aspecific Needle Skin Stimulation
Launched by MONTECATONE REHABILITATION INSTITUTE S.P.A. · May 30, 2017
Trial Information
Current as of June 26, 2025
Terminated
Keywords
ClinConnect Summary
About 67% of patients with spinal cord injury (SCI) experience painful symptoms in the course of life after injury and a third evaluates the pain as "severe", with a significant impact on quality of life, due to limitations in daily activities and autonomy. Persistent pain can be of different origin and may be nociceptive, neuropathic or mixed. However, it is often poorly responsive to pharmacological therapy. For some years, attention has been paid to the use of non-pharmacological therapies and interventional techniques in treating pain, and acupuncture has been the treatment most used an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Persistent pain: NRS score \>2 in at least 5 assessments in 5 consecutive days, despite usual antalgic management;
- • Spinal cord injury due to any etiology (both traumatic and non-traumatic);
- • Spinal cord injury of any neurological level, complete or incomplete, classifiable as Asia Impairment Score (AIS) A, B, C or D;
- • Stable medical conditions;
- • At least 1 month away from the spinal cord injury event.
- Exclusion Criteria:
- • Sporadic pain;
- • Mechanical ventilation;
- • Pregnancy;
- • Disorders of consciousness;
- • Incapacity to give informed consent in person.
About Montecatone Rehabilitation Institute S.P.A.
Montecatone Rehabilitation Institute S.p.A. is a leading healthcare organization specializing in advanced rehabilitation services for patients with complex neurological and musculoskeletal disorders. Located in Italy, the institute is renowned for its commitment to innovative therapeutic approaches and evidence-based practices. With a multidisciplinary team of experts, Montecatone focuses on enhancing patient outcomes through personalized rehabilitation programs, cutting-edge research, and collaboration with academic institutions. As a prominent clinical trial sponsor, the institute plays a vital role in advancing medical knowledge and improving treatment options in the field of rehabilitation medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Imola, Bo, Italy
Patients applied
Trial Officials
Angela Morreale, MD
Principal Investigator
Montecatone Rehabilitation Institute S.p.A.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials